Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies
复制标题
DOI:
10.1016/s0264-410x(03)00355-4
复制
发表时间:
2003-07-28
期刊:
影响因子:
5.5
通讯作者:
Glezen, WP
中科院分区:
文献类型:
--
作者:
Piedra, PA;Jewell, AM;Glezen, WP
Objective: To determine if respiratory syncytial virus (RSV) specific, serum antibody titers correlate with protection against RSV associated-hospitalization at all ages.Design: Participants who were enrolled in a trial to determine the frequency of specific virus infections associated with hospitalization [J. Am. Med. Assoc. 283 (2000) 499] were included in our analysis if they were enrolled from July 1991 to June 1993, had a culture for virus isolation, and provided blood samples at hospitalization and 14-60 days later. RSV infection was defined by a positive culture and/or serology. Microneutralization, ELISA to the fusion (F) protein and Western blot were the serological assays that were used to determine correlates of immunity.Results: One hundred and seventy-five individuals, I month to 89 years old, out of 538 patients hospitalized with an acute respiratory infection met the criteria for analysis. RSV as sociated-hospitalization occurred in 11 (40.7%) of 27 infants (< 1 year), 8 (38.1%) of 21 young children (1 to